Healing ePharmacy Market Reshapes Healthcare Landscape

According to latest research report published by Market Data Forecast, the ePharmacy market will be worth USD 67.43 billion in 2024 and USD 146.65 billion by 2029, growing at a CAGR of 7.83 % from 2024 to 2029.

ePharmacy is the business concept that deals with preparing and selling prescription and non-prescription pharmaceuticals. The online pharmacies accept the orders online and mail the medications to their intended recipients.

Global ePharmacy Report Scope:
• Market Size (2029): USD 146.65 Billion
• Market Size (2024): USD 67.43 Billion
• CAGR (2024 to 2029): 16.81%
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: Drug Type, Product Type, and Region
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa
• Key Market Players Profiled are CVS Health, Walmart Stores, Inc., Walgreen Co., The Kroger Co., Rite Aid Corp, Lloyds Pharmacy Ltd., Planter, Canada Drugs, Medicate, Express Scripts Holding Company, Secure Medical Inc., Sani care A.B., Doctors Rowlands Pharmacy, Giant Eagle, Inc. AND Optus Rx, Inc.

Avail sample market brochure of the report, ask @ https://www.marketdataforecast.com/market-reports/global-e-pharmacy-market/request-sample

The increasing adoption of digital healthcare worldwide as the internet has become an integral part of people's lives, prominently contributing to the growth of the global ePharmacy market. The growing digitalization of healthcare services and increasing consumer preference for online stores boost the global ePharmacy market expansion. The availability of various medications at low cost and generic medications are fueling the market growth. For Instance, in 2022, venture capitalist Mark Cuban launched a digital pharmacy that sells more than 100 generic pharmaceuticals at low cost. Specific advantages of ePharmacy, like door-step delivery, which majorly helps non-movable patients, enhance the adoption rate among the people, and increases the market revenue. The increasing penetration of smartphones with the Internet of Things (IoT) is increasing the use of intelligent technologies like ePharmacy rather than physical effort-the increased influence of the pandemic changed the priorities of the healthcare system worldwide. Online pharmacies emerged as one of the largest beneficiaries of the pandemic-induced lockdown as people preferred buying medicines online to reduce the spread of infection. The flu pandemic is increasing consumer adoption and propelling global market revenue. The increasing consumer concern for convenience, affordability, and accessibility, which is being offered by digital pharmacy platforms, is gaining the consumer base by escalating the global market growth. The growing market trends of telemedicine and telehealth, the increasing geriatric population, and technology adoption in the healthcare system are all propelling the adoption of ePharmacy by raising the market share.

Few illegal online pharmacies are the primary factor restraining the adoption of ePharmacy worldwide. Most of these unlicensed pharmacies are expected to sell drugs unapproved by the FDA, increasing the number of contaminated medications and hampering the expansion of the pharmacy market. For Instance, the FDA released a list of online pharmacies that are acting illegally, which received warning letters in 2021. There is a high chance of data breaches and unauthorisation of the sites as the patient information is present with the online pharmacies. The chance of delivering wrong medication and delivery delays in emergency situations are expected to limit the expansion of the ePharmacy market worldwide.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/global-e-pharmacy-market

Key Insights from The Report:
• Based on Drug Type, the OTC drug segment is expected to grow at the fastest CAGR during the forecast period.
• Based on Product Type, the cold and flu segment is expected to grow at the fastest CAGR during the forecast period.
• North America dominated the ePharmacy market in 2023. Europe accounted for second-highest share of the global market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• CVS Health, Walmart Stores, Inc., Walgreen Co., The Kroger Co., Rite Aid Corp, Lloyds Pharmacy Ltd., Planter, Canada Drugs, Medicate, Express Scripts Holding Company, Secure Medical Inc., Sani care A.B., Doctors Rowlands Pharmacy, Giant Eagle, Inc. AND Optus Rx, Inc are dominated the ePharmacy market.

The report can be customized as per the requirements, ask @ https://www.marketdataforecast.com/market-reports/global-e-pharmacy-market/customization

SEGMENTATION INCLUDED IN THIS REPORT:

By Drug Type:
• Prescription Drugs
• Over-the-Counter Drugs
By Product Type:
• Skin Care
• Dental
• Cold And Flu
• Vitamins
• Weight Loss
• Others
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:

North America ePharmacy Market Research Report - Segmented By Product Type, Drug Type & Country (the United States, Canada and Rest of North America) - Industry Analysis on Size, Share, Trends, Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/north-america-e-pharmacy-market
Europe ePharmacy Market (Online Pharmacy Market) Research Report - Segmented By Product Type, Drug Type, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/europe-e-pharmacy-market
Asia Pacific ePharmacy Market (Online Pharmacy Market) Research Report - Segmented By Product Type, Drug Type, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/apac-e-pharmacy-market
Latin America ePharmacy Market Research Report - Segmented By Product Type, Drug Type, Country (Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029) - https://www.marketdataforecast.com/market-reports/latin-america-e-pharmacy-market

TABLE OF CONTENTS:

1. Introduction
1.1. Market Definition
1.2. Study Deliverables
1.3. Base Currency, Base Year and Forecast Periods
1.4. General Study Assumptions
2. Research Methodology
2.1. Introduction
2.2. Research Phases
2.2.1. Secondary Research
2.2.2. Primary Research
2.2.3. Econometric Modelling
2.2.4. Expert Validation
2.3. Analysis Design
2.4. Study Timeline
3. Overview
3.1. Executive Summary
3.2. Key Inferences
3.3. New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1. Market Drivers
4.2. Market Restraints
4.3. Key Challenges
4.4. Current Opportunities in the Market
5. Market Segmentation
5.1. By Drug Type
5.1.1. prescription drugs
5.1.2. over the counter drugs
5.1.3. Y-o-Y Growth Analysis, By Drug Type
5.1.4. Market Attractiveness Analysis, By Drug Type
5.1.5. Market Share Analysis, By Drug Type
5.2. By Product Type
5.2.1. skin care
5.2.2. dental
5.2.3. cold and flu
5.2.4. vitamins
5.2.5. weight loss
5.2.6. others
5.2.7. Y-o-Y Growth Analysis, By Product Type
5.2.8. Market Attractiveness Analysis, By Product Type
5.2.9. Market Share Analysis, By Product Type
6. Geographical Analysis
6.1. Introduction
6.1.1. Regional Trends
6.1.2. Impact Analysis
6.1.3. Y-o-Y Growth Analysis
6.1.3.1. By Geographical Area
6.1.3.2. By Drug Type
6.1.3.3. By Product Type
6.1.4. Market Attractiveness Analysis
6.1.4.1. By Geographical Area
6.1.4.2. By Drug Type
6.1.4.3. By Product Type
6.1.5. Market Share Analysis
6.1.5.1. By Geographical Area
6.1.5.2. By Drug Type
6.1.5.3. By Product Type
6.2. North America
6.2.1. Introduction
6.2.2. US
6.2.3. Canada
6.3. Europe
6.3.1. Introduction
6.3.2. UK
6.3.3. France
6.3.4. Spain
6.3.5. Germany
6.3.6. Italy
6.4. Asia-Pacific
6.4.1. Introduction
6.4.2. India
6.4.3. China
6.4.4. Japan
6.4.5. South Korea
6.4.6. Australia
6.5. Latin America
6.5.1. Introduction
6.5.2. Brazil
6.5.3. Argentina
6.5.4. Mexico
6.6. Middle East & Africa
6.6.1. Introduction
6.6.2. Middle East
6.6.3. Africa
7. Strategic Analysis
7.1. PESTLE analysis
7.1.1. Political
7.1.2. Economic
7.1.3. Social
7.1.4. Technological
7.1.5. Legal
7.1.6. Environmental
7.2. Porter's Five analysis
7.2.1. Bargaining Power of Suppliers
7.2.2. Bargaining Power of Consumers
7.2.3. Threat of New Entrants
7.2.4. Threat of Substitute Products and Services
7.2.5. Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1. Lloyds Pharmacy Ltd.
8.1.1. Overview
8.1.2. Product Analysis
8.1.3. Strategic Evaluation and Operations
8.1.4. Financial analysis
8.1.5. Legal issues
8.1.6. Recent Developments
8.1.7. SWOT analysis
8.1.8. Analyst View
8.2. Planter
8.3. CVS Health
8.4. Canada Drugs
8.5. Medicate
8.6. Express Scripts Holding Company
8.7. Secure Medical Inc.
8.8. Walmart Stores Inc.
8.9. com Inc.
8.10. Sani care AB
8.11. Walgreen Co.
8.12. The Kroger Co.
8.13. Doctors Rowlands Pharmacy
8.14. Giant Eagle Inc.
8.15. Optus Rx Inc.
9. Competitive Landscape
9.1. Market share analysis
9.2. Merger and Acquisition Analysis
9.3. Agreements, Collaborations and Joint Ventures
9.4. New Product Launches
10. Market Outlook and Investment Opportunities
11. Appendix
11.1. List of Tables
11.2. List of Figures

Contact Us:
Market Data Forecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.